Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP119) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP119

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 2102-2109

  Ahlborg, Niklas ^a,d   Ling, Irene T ^b   Holder, Anthony A ^b   Riley, Eleanor M ^a,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Mabtech AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MALARIA; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; GLUTATHIONE TRANSFERASE; H-2 ANTIGENS; HAPLOTYPES; IMMUNIZATION; IMMUNOGLOBULIN G; MALARIA; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, CONGENIC; PLASMIDS; PLASMODIUM YOELII; RECOMBINANT FUSION PROTEINS; TIME FACTORS;

EID: 0034104387     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.2102-2109.2000     Document Type: Article

References (64)

1. Ahlborg, N. 1995. Synthesis of a diepitope MAP containing two malaria antigen sequences using Fmoc chemistry. J. Immunol. Methods 179:269-275.
2. Ahlborg, N., S. Paulie, and S. Braesch-Andersen. 1997. Generation of antibodies to human IL-12 and amphiregulin by immunization of Balb/c mice with diepitope multiple antigen peptides. J. Immunol. Methods 204:23-32.
3. k-restricted T-cell epitopes in the highly repetitive Plasmodium faiciparum antigen Pf332. Mol. Immunol. 34:379-389.
4. Amante, F., and M. Good. 1997. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice. Parasite Immunol. 19:111-126.
5. Blackman, M., E. Dennis, E. Hirst, C. Kocken, T. Scolt-Finnigan, and A. Thomas. 1996. Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1. Exp. Parasitol. 83:229-239.
6. Blackman, M., H. Heidrich, S. Donachie, J. McBride, and A. Holder. 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379-382.
7. 33 as a non-covalently associated complex with other fragments of the MSP1. Mol. Biochem. Parasitol. 50:307-315.
8. Blackman, M., I. Ling, S. Nicholls, and A. Holder. 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49:29-33.
9. Blackman, M., T. Scott-Finnigan, S. Shai, and A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389-393.
10. Burghaus, P., B. Wellde, T. Hall, R. Richards, A. Egan, E. Riley, W. Ballou, and A. Holder. 1996. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection. Infect. Immun. 64:3614-3619.
11. Cavanagh, D., and J. McBride. 1997. Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Mol. Biochem. Parasitol. 85:197-211.
12. Chang, S., S. Case, W. Gosnell, A. Hashimoto, K. Kramer, L. Tam, C. Hshiro, C. Nikaido, H. Gibson, C. Lee-Ng, P. Barr, B. Yokota, and G. Hui. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253-261.
13. Comoy, E., A. Capron, and G. Thyphronitis. 1997. In vivo induction of type 1 and 2 immune responses against protein antigens. Int. Immunol. 9:523-531.
14. Daly, T., and C. Long. 1995. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 155:236-243.
15. Daly, T., and C. Long. 1996. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection. Infect. Immun. 64: 2602-2608.
16. Daly, T. M., and C. A. Long. 1993. A recombinant 15-kilodalton carboxylterminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61: 2462-2467.
17. David, P., T. Hadley, M. Aikawa, and L. Miller. 1984. Processing of a major parasite surface glycoprotein during the ultimate stages of differentiation in Plasmodium knowlesi. Mol. Biochem. Parasitol. 11:267-282.
18. De Kruyff, R., L. Rizzo, and D. Umetsu. 1993. Induction of immunoglobulin synthesis by CD4+ T cell clones. Semin. Immunol. 5:421-430.
19. Diamond, B., and D. Yelton. 1981. A new Fc receptor on mouse macrophages binding IgG3. J. Exp. Med. 153:514-519.
20. Egan, A., J. Morris, G. Barnish, S. Allen, B. Greenwood, D. Kaslow, A. Holder, and E. Riley. 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 173:765-769.
21. Egan, A., M. Waterfall, M. Pinder, A. Holder, and E. Riley. 1997. Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infect. Immun. 65:3024-3031.
22. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. H. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglohulin isotype selection. Annu. Rev. Immunol. 8:303-333.
23. Freeman, R., and A. Holder. 1983. Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen. Clin. Exp. Immunol. 54:609-616.
24. Gavin, A., N. Barnes, H. Dijstelbloem, and P. Hogarth. 1998. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J. Immunol. 160:20-23.
25. Germann, T., M. Bongartz, H. Dlugonska, H. Hess, E. Schmitt, L. Kolbe, E. Kolsch, F. Podlaski, M. Gately, and E. Rude. 1995. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25:823-829.
26. Gill, S., and P. von Hippel. 1989. Calculation of protein extinction coefficients from amino acid sequence data Anal. Biochem. 182:319-326. (Erratum, 189:283, 1990.)
27. Hayglass, K., and W. Stefura. 1991. Antigen-specific inhibition of ongoing murine IgE responses. II. Inhibition of IgE responses induced by treatment with glutaraldehyde-modified allergens is paralleled by reciprocal increases in IgG2a synthesis. J. Immunol. 147:2455-2460.
28. Hirunpetcharat, C., J. Tian, D. Kaslow, N. van Rooijen, S. Kumar, J. Berzofsky, L. Miller, and M. Good. 1997. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J. Immunol. 159: 3400-3411.
29. Holder, A. A., and R. R. Freeman. 1984. Characterization of a high molecular weight protective antigen of Plasmodium yoelii. Parasitology 88:211-219.
30. Howard, R., and B. Pasloske. 1993. Target antigens for asexual malaria vaccine development. Parasitol. Today 9:369-372.
31. Hui, G. S., and C. N. Hashimoto. 1998. Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1. Infect. Immun. 66:5329-5336.
32. Kang, Y., P. Calvo, T. Daly, and C. Long. 1998. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite. J. Immunol. 161:4211-4219.
33. Kumar, A., R. Arora, P. Kaur, V. Chauhan, and P. Sharma. 1992. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. J. Immunol. 148:1499-1505.
34. Kumar, S., A. Yadava, D. Keister, J. Tian, M. Ohl, K. Perdue-Greenfield, L. Miller, and D. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325-332.
35. Lewis, A. 1989. Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoelii. Mol. Biochem. Parasitol. 36: 271-282.
36. Ling, I., S. Ogun, and A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol. 16:63-67.
37. Ling, I., S. Ogun, and A. Holder. 1995. The combined epidermal growth factor-like modules of Plasmodium yoelii merozoite surface protein-1 are required for a protective immune response to the parasite. Parasite Immunol. 17:425-433.
38. Ling, I., S. Ogun, P. Momin, R. Richards, N. Garcon, J. Cohen, W. Ballou, and A. Holder. 1997. Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. Vaccine 15:1562-1567.
39. Majarian, W., T. Daly, W. Weidanz, and C. Long. 1984. Passive immunization against murine malaria with an IgG3 monoclonal antibody. J. Immunol. 132:3131-3137.
40. Martin, R., J. Brady, and A. Lew. 1998. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212:187-192.
41. Matsumoto, S., H. Yukitake, H. Kanbara, and T. Yamada. 1998. Recombinant Mycobacterium bovin bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. J. Exp. Med. 188:845-854.
42. Mosmann, T., and R. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
43. O'Dea, K. P., P. G. McKean, A. Harris, and K. N. Brown. 1995. Processing of the Plasmodium chahaudi chabaudi AS merozoite surface protein 1 in vivo and in vitro. Mol. Biochem. Parasitol. 72:111-119.
44. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous recognition by T cells. Eur. J. Immunol. 19:2237-2242.
45. Patino, J., A. Holder, J. McBride, and M. Blackman. 1997. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 186: 1689-1699.
46. Perera, K., S. Handunetti, I. Holm, S. Longacre, and K. Mendis. 1998. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect. Immun. 66:1500-1506.
47. Peters, W. 1967. Chemotherapy of Plasmodium chabaudi infection in albino mice. Ann. Trop. Med. Parasitol. 61:52-56.
48. Qari, S., Y.-P. Shi, I. Goldman, B. Nahlen, M. Tibayrenc, and A. Lal. 1998. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP1), a potential malaria vaccine antigen. Mol. Biochem. Parasitol. 92:241-252.
49. Ravetch, J., and J.-P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9: 457-492.
50. Rotman, H., T. Daly, R. Clynes, and C. Long. 1998. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. J. Immunol. 161:1908-1912.
51. Shai, S., M. Blackman, and A. Holder. 1995. Epitopes in the 19kDa fragment of the Plasmodium falciparum major merozoite surface protein-1 (PfMSP-1(19)) recognized by human antibodies. Parasite Immunol. 17:269-275.
52. Shi, Y., U. Sayed, S. Qari, J. Roberts, V. Udhayakumar, A. Oloo, W. Hawley, D. Kaslow, B. Nahlen, and A. Lal. 1996. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect. Immun. 64:2716-2723.
53. Sjölander, A., N. Ahlborg, S. Ståhl, and R. Andersson. 1998. Characterization of immune responses to experimental polyvalent subunit vaccines assembled in iscoms. Mol. Immunol. 35:159-166.
54. Smith, D., and K. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 6:31-40.
55. Spencer Valero, L. M., S. A. Ogun, S. L. Fleck, I. T. Ling, T. J. Scott-Finnigan, M. J. Blackman, and A. A. Holder. 1998. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia. Infect. Immun. 66:3925-3930.
56. Tam, J. 1988. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigen system. Proc. Natl. Acad. Sci. USA 85:5409-5413.
57. Tanabe, K., M. Mackay, M. Goman, and J. Scaife. 1987. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 195:273-287.
58. Tian, J. H., M. F. Good, C. Hirunpetcharat, S. Kumar, I. T. Ling, D. Jackson, J. Cooper, J. Lukszo, J. Coligan, J. Ahlers, A. Saul, J. A. Berzofsky, A. A. Holder, L. H. Miller, and D. C. Kaslow. 1998. Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria. Parasite Immunol. 20:263-278.
59. Tian, J. H., L. Miller, D. Kaslow, J. Ahlers, M. Good, D. Alling, J. Berzofsky, and S. Kumar. 1996. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J. Immunol. 157:1176-1183.
60. White, W., C. Evans, and D. Taylor. 1991. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infect. Immun. 59:3547-3554.
61. Yang, C., W. E. Collins, J. S. Sullivan, D. C. Kaslow, L. Xiao, and A. A. Lal. 1999. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant. Infect. Immun. 67:342-349.
62. Yang, C., W. Collins, L. Xiao, P. Patterson, R. Reed, R. Hunter, D. Kaslow, and A. Lal. 1996. Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1). Parasite Immunol. 18:182-185.
63. Yoeli, M., B. Hargreaves, R. Carter, and D. Walliker. 1975. Sudden increase in virulence in a strain of Plasmodium berghei yoelii. Ann. Trop. Med. Parasitol. 69:173-178.
64. Zhang, L., and S. S. Mohaptra. 1993. Antigen- and isotype-specific immune responses to a recombinant antigen-allergen chimeric (RAAC) protein. J. Immunol. 151:791-799.